A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES

查看最新文献

493

A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES - 最新文献

Tolerability and Overall Mortality in Patients With Non-idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease Treated With Nintedanib: Real-world Evidence From a Single Specialist Centre

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1522 P. Rivera Ortega, L. Stranks, K. Newman, T. Garfoot, H. Morris, K. Zakis, J. Swale, M. Greaves, S. Stanel, C. Avram, J. Blaikley, C. Hayton, C. Leonard

Variation in Treatment Efficacy of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF) Over 2 Years

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1520 N. Arai

Health-related Quality of Life in Patients With Rheumatoid Arthritis (RA) Vs RA-associated Interstitial Lung Disease

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1514 Y. Sugawara, F. Ahmed, J. Solomon

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。